Consensus
The community sees this as very unlikely for Merck & Co at 13%, based on 5 forecasts. Forecasters are in moderate agreement.
Resolves YES if Merck & Co is down more than 33% 12 months out versus its baseline price.
Share your read on this question — the best forecasters show their work.
See the whole mrk discussion →